The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products

INTRODUCTION: Pharmaceutical risk minimization programs involve interventions designed to support safe and appropriate use of medicines. Currently, information regarding the evaluation of these programs is not publicly reported in a standardized and transparent manner. To address this gap, we develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Meredith Y., Russell, Andrea, Bahri, Priya, Mol, Peter G. M., Frise, Sarah, Freeman, Emily, Morrato, Elaine H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878197/
https://www.ncbi.nlm.nih.gov/pubmed/29218682
http://dx.doi.org/10.1007/s40264-017-0619-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5878197/
https://www.ncbi.nlm.nih.gov/pubmed/29218682
http://dx.doi.org/10.1007/s40264-017-0619-x

Ejemplares similares